Pfizer Inc.

Treatment resistance is one of the biggest challenges in advanced prostate cancer, making the disease more difficult to treat and highlighting the need for new approaches.

At Pfizer, our researchers are studying EZH2 and whether targeting it could help restore sensitivity to hormone therapy.

Learn more: bit.ly/3UwUcDl

BMI has been widely used to define obesity—but was it ever built for that job?

The first episode of #ScienceWillWin’s latest season, with host @DrJoeHanson, explores BMI’s history, its limitations, and how science is moving toward a more nuanced understanding of #obesity.

🎧 Tune in here: on.pfizer.com/4jUNphk

250 years of American innovation have shown what’s possible when different minds and ideas come together.

As we look to what’s next, Pfizer is proud to build on that spirit of innovation, continuing to advance science and explore what’s possible for the future of medicine. Learn more: bit.ly/4zh91sV

#America250

See how Pfizer is using AI to help support precise and efficient manufacturing through our #GoldenBatch platform by turning complex production data into actionable insights.

#ArtificialIntelligence #Manufacturing

Obesity isn’t simply about weight. It’s linked to inflammation, insulin resistance, and 200+ other conditions.

Pfizer’s Lisa Tarasenko explains why treating obesity as a chronic disease, not a personal failing, is reshaping care.

on.pfizer.com/3ULDmRq

#ObesityCare #ChronicDisease